Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation
Authors:
- 29 August 2016
- journal article
- research article
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 31 (10) , 648-653
Abstract
The use of left ventricular assist devices (LVAD) has increased significantly in the last decade. However, right heart dysfunction remains a problem despite the improved outcomes with continuous-flow LVADs. Surgical options for bridge to transplantation (BTT) in patients with biventricular failure are total artificial heart (TAH) or biventricular support (BiVAD). This study examines the differences in pre- and post-transplantation outcomes and survival in patients with TAH or BiVAD support as BTT. The United Network of Organ Sharing database was retrospectively queried from January 2005 to December 2014 to identify adult patients undergoing heart transplantation (n = 17,022). Patients supported with either TAH (n = 212) or BiVAD (n = 366) at the time of transplantation were evaluated. Pre- and post-transplantation Kaplan–Meier survival curves were examined. Cox regression model was used to study the hazard ratios of the association between TAH versus BiVAD support and post-transplant survival. The median age of the study groups was 49.8 ± 12.9 (TAH) and 47.2 ± 13.9 (BiVAD) years (range 18–74 years). There were more men, 87% versus 74%, in the TAH group (p < 0.0001) with greater body mass index, 27.3 ± 5.2 versus 25.6 ± 4.7 (p < 0.0001), compared to those with BiVADs. Creatinine was higher, 1.7 + 1.2 versus 1.3 + 0.8 mg/dL (p < 0.0001), in the TAH group before transplant. The 30-day, one-, and three-year post-transplantation survival was 88%, 78%, and 67%, respectively, for patients with TAH support versus 93%, 83%, and 73% (p = 0.06) for patients with BiVAD support. Cox regression model shows pre-transplant creatinine (HR = 1.21, p = 0.008) is associated with a lower post-transplant survival. TAH is not associated with a worse post-transplant survival (p = 0.1). There was no difference in wait-list survival in patients supported with TAH or BiVAD (p = 0.8). Although there has been a recent increase in the use of the TAH as BTT, BiVAD support remains a viable option with similar post-transplant survival.Keywords
Funding Information
- Health Resources and Services Administration Contract (234-2005-37011C)
This publication has 11 references indexed in Scilit:
- Seventh INTERMACS annual report: 15,000 patients and countingThe Journal of Heart and Lung Transplantation, 2015
- Results With Syncardia Total Artificial Heart Beyond 1 YearASAIO Journal, 2014
- Pro: The Total Artificial Heart: Is It an Appropriate Replacement for Existing Biventricular Assist Devices?Journal of Cardiothoracic and Vascular Anesthesia, 2014
- Sixth INTERMACS annual report: A 10,000-patient databaseThe Journal of Heart and Lung Transplantation, 2014
- Executive Summary: Heart Disease and Stroke Statistics—2014 UpdateCirculation, 2014
- OPTN/SRTR 2012 Annual Data Report: HeartAmerican Journal of Transplantation, 2014
- SynCardia Temporary Total Artificial Heart as Bridge to Transplantation: Current Results at La Pitié HospitalThe Annals of Thoracic Surgery, 2013
- Survival after biventricular mechanical circulatory support: Does the type of device matter?The Journal of Heart and Lung Transplantation, 2012
- Experience with more than 100 total artificial heart implantsThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009